SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001618835-20-000105
Filing Date
2020-05-06
Accepted
2020-05-06 08:11:04
Documents
65
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q evfm-331202010xq.htm 10-Q 825882
2 EXHIBIT 10.2 a102firstamendmentredacted.htm EX-10.2 46219
3 EXHIBIT 31.1 evfm-3312020ex311.htm EX-31.1 21660
4 EXHIBIT 31.2 evfm-3312020ex312.htm EX-31.2 21898
5 EXHIBIT 32.1 evfm-3312020ex321.htm EX-32.1 13244
12 leaseamendmentredacte_image1.gif GRAPHIC 33692
  Complete submission text file 0001618835-20-000105.txt   5675299

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT evfm-20200331.xml EX-101.INS 1023106
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evfm-20200331.xsd EX-101.SCH 52140
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT evfm-20200331_cal.xml EX-101.CAL 63883
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evfm-20200331_def.xml EX-101.DEF 297276
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evfm-20200331_lab.xml EX-101.LAB 635490
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evfm-20200331_pre.xml EX-101.PRE 401128
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36754 | Film No.: 20851213
SIC: 2834 Pharmaceutical Preparations